WDAY (NASDAQ: WDAY) Rule 144 notice lists 107,500 shares; trust 10b5‑1 sales shown

Rhea-AI Filing Summary

WDAY — Notice of proposed resale of common stock under Rule 144. The filing lists 107,500 shares of Common Stock associated with a private placement dated 12/27/2007. The excerpt also records multiple 10b5-1 sales by the David A. Duffield Trust on 03/02/2026 through 04/06/2026 showing per‑trade proceeds (examples: $14,447,903.25 on 03/02/2026, $13,932,096.75 on 04/06/2026). The filing is a Rule 144 notice of resale; timing and aggregate proceeds beyond the listed trade lines are not stated in the excerpt.

Insights

Securities Counsel

Rule 144 notice records proposed resale and contemporaneous 10b5‑1 dispositions.

The filing lists 107,500 shares of Common Stock tied to a prior private placement (12/27/2007) and shows multiple 10b5‑1 sales by the named trust between 03/02/2026 and 04/06/2026. Rule 144 notices typically accompany planned resales of restricted or controlled securities.

Cash‑flow treatment for the issuer is not stated in the excerpt; these lines show trade proceeds by date and are consistent with planned 10b5‑1 executions. Subsequent filings would show whether these specific lots were cleared under Rule 144 or sold under alternate exemptions.

Key Figures

Shares listed for resale: 107,500 shares Example proceeds: $14,447,903.25 Example proceeds: $13,932,096.75 +1 more

4 metrics

Shares listed for resale 107,500 shares private placement dated 12/27/2007

Example proceeds $14,447,903.25 proceeds reported for sale on 03/02/2026

Example proceeds $13,932,096.75 proceeds reported for sale on 04/06/2026

Trade date range shown 03/02/2026–04/06/2026 dates of multiple 10b5‑1 sales by the trust

Key Terms

Rule 144, 10b5‑1, Private Placement

3 terms

Rule 144 regulatory

"Notice of proposed resale of restricted or control securities"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5‑1 regulatory

"10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88"

Private Placement market

"Private Placement | Issuer | 12/27/2007"

A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	107500	12810775.00	210000000	04/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2007	Private Placement	Issuer			107500	12/27/2007	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	04/06/2026	107500	13932096.75
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/31/2026	107500	13949221.50
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/26/2026	107500	13797431.50
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/23/2026	107500	14708644.50
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/18/2026	107500	14252006.00
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/13/2026	107500	14262347.50
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/10/2026	107500	15284231.75
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/05/2026	107500	15819248.50
10b5-1 Sales for DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	03/02/2026	107500	14447903.25

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does WDAY's Form 144 list as the shares to be sold?

It lists 107,500 shares of Common Stock. The excerpt ties those shares to a private placement dated 12/27/2007 and identifies the securities class as Common Stock.

Who executed the listed 10b5‑1 sales in the WDAY excerpt?

Sales are shown for the David A. Duffield Trust U/T/A 7/14/88. Multiple dated entries from 03/02/2026 through 04/06/2026 list 10b5‑1 sales and corresponding proceeds.

What proceeds are shown for the example 10b5‑1 trades?

Examples show proceeds around $13.9M–$15.8M per line. The excerpt includes amounts such as $14,447,903.25 on 03/02/2026 and $13,932,096.75 on 04/06/2026.

Does the filing state how the company will receive proceeds from these sales?

No issuer proceeds are specified in the excerpt. The lines report sales by a trust under 10b5‑1; the filing does not state any cash will be received by the issuer.